Product Information
DEPO-PROVERA 150 MG/ML SYRINGE is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $52.4450 per ML under NDC 00009737611. Its NADAC has been published 363 times since Apr 23, 2014.
The High Outlier badge above means this manufacturer's average price in the medroxyprogesterone acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/mL
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009737611
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Last Updated
6/17/2026
Active Ingredients
MEDROXYPROGESTERONE ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA020246On Market Since
10/29/1992
Pharmacological Classes
Price Statistics
The NADAC for DEPO-PROVERA 150 MG/ML SYRINGE has been published 363 times since Apr 23, 2014, and over the history we have for it it has declined 53.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $52.4450 per ML |
|---|---|
| All-time high | $193.2580 (Jan 16, 2019) |
| All-time low | $52.4418 (May 20, 2026) |
| 52-week high | $52.8975 |
| 52-week low | $52.4418 |
| Median price | $134.0259 |
| Average price | $122.9014 |
| Largest weekly change | -72.7% (Apr 17, 2024) |
| Weeks tracked | 363 |
| Tracking since | Apr 23, 2014 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 64% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEPO-PROVERA 150 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for DEPO-PROVERA 150 MG/ML SYRINGE, manufactured by Pharmacia & Upjohn Company LLC, is $52.4450 per ML (NDC 00009737611), effective Jun 24, 2026.
How has the price of DEPO-PROVERA 150 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for DEPO-PROVERA 150 MG/ML SYRINGE has declined 53.9%. It has been tracked across 363 weekly CMS publications since Apr 23, 2014.
What are the highest and lowest recorded NADAC prices for DEPO-PROVERA 150 MG/ML SYRINGE?
Since Apr 23, 2014, the NADAC for DEPO-PROVERA 150 MG/ML SYRINGE has ranged from a low of $52.4418 (May 20, 2026) to a high of $193.2580 (Jan 16, 2019), with a median of $134.0259 per ML.
Are there cheaper alternatives to DEPO-PROVERA 150 MG/ML SYRINGE?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, MEDROXYPROGESTERONE 150 MG/ML, is $18.7597 per ML — about 64% below DEPO-PROVERA 150 MG/ML SYRINGE.
Who manufactures DEPO-PROVERA 150 MG/ML SYRINGE?
DEPO-PROVERA 150 MG/ML SYRINGE (NDC 00009737611) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification